Interleukin-10 (IL-10) is a cytokine with antiinflammatory effects. In a rabbit model of meningitis, IL-10 was given intracisternally or intravenously to evaluate the impact on inflammation induced by lipooligosaccharide (LOS), Haemophilus influenzae type b (Hib), or Listeria monocytogenes. Intracisternal IL-10 in concentrations ú1 mg significantly reduced tumor necrosis factor-a (TNFa) and lactate values in cerebrospinal fluid (CSF). Intravenous IL-10 (1 mg/kg) in two doses after intracisternal LOS significantly reduced CSF TNF-a and lactate. When Hib was used, animals were treated with ceftriaxone and dexamethasone with or without IL-10 (1 mg/kg). TNF-a was significantly reduced in animals treated with IL-10, dexamethasone, or both compared with levels in rabbits receiving ceftriaxone alone. Comparable results were obtained when L. monocytogenes was inoculated and animals were treated with ampicillin with or without IL-10, dexamethasone, or nothing. In conclusion, IL-10 modulates CSF TNF-a concentrations in experimental LOS, Hib, or L. monocytogenes meningitis. The maximal inhibitory effect was seen when IL-10 and dexamethasone were combined.
Cytokines play an important role in the pathophysiology of clonal antibody [10] , and pentoxifylline [12] on the cerebrospinal fluid (CSF) inflammatory response after intracisternal inocmeningitis. In animal models [1] and clinical studies [2, 3] , we demonstrated strong correlations between tumor necrosis ulation of different bacterial strains, homologous cytokines (TNF-a and IL-1b), or endotoxin into rabbits. Both pentoxifylfactor-a (TNF-a) and interleukin-1b (IL-1b) and alteration of blood-brain barrier permeability, cerebral edema, and clinical line and anti-CD18 monoclonal antibody alone or combined with dexamethasone decreased inflammation in experimental severity of disease in patients with bacterial meningitis. Additionally, concentrations of TNF-a have been correlated with meningitis [10, 12] . Dexamethasone was later shown in clinical trials to significantly reduce long-term morbidity in children outcome of sepsis in children [4] and of meningococcemia [5] . TNF-a and IL-1a and -1b produce both a local inflammatory with bacterial meningitis [13 -15] . Although dexamethasone can improve the outcome in children with bacterial meningitis, response and a systemic vascular endothelial response that includes formation and stabilization of thrombi and production it is not effective in all cases, especially when antibiotics are administered before steroids. of nitric oxide synthase [6 -8] .
In recent years, various approaches to modulate the inflam-IL-10, a newly discovered cytokine with antiinflammatory activities, has been shown to be produced by T cells, macromatory response induced by these cytokines have been investigated in animal models. In our laboratory, we demonstrated phages, keratinocytes, and B cells [16 -21] . Multiple in vitro effects have been reported, including inhibition of the synthesis the modulatory effect of dexamethasone [9, 10] , IL-1 receptor antagonist [11] , soluble TNF receptor [11] , anti-CD18 monoand gene expression in monocytes and neutrophils of IL-1, TNF, IL-6, IL-8, and colony-stimulating factors [22, 23] . In addition to inhibiting the production of cytokines and nitric oxide, IL-10 prevents macrophage cytotoxic activity [24] . JID 1997; 176 (November) of Texas Southwestern Medical Center at Dallas) and prepared as Table 2 . Cerebrospinal fluid tumor necrosis factor-a (TNF-a) concentrations in rabbits inoculated with lipooligosaccharide intracisdescribed previously [29, 30] .
ternally and treated intravenously with different dosages of IL-10. Bacterial strains. Hib strain DL 42 was isolated from CSF of a child with meningitis [9] . About 10 6 cfu/mL in log-phase growth TNF-a concentration (pg/mL) diluted in 0.5 mL of pyrogen-free PBS was inoculated intracisternally. The next experiments involved intracisternal inoculation of dure, animals received ketamine (50 mg/kg) and acepromazine (3 Ç10 6 cfu/mL Hib and intravenous treatment with ceftriaxone (100 mg/kg) intramuscularly. At designated times, 200-300 mg/mL mg/kg), IL-10 (1 mg/kg, two doses 1 h apart), and/or dexametha-CSF was withdrawn. At the end of the experiments, animals were sone (1 mg/kg). Treatment was initiated 6 h after the intracisternal sacrificed by intravenous pentobarbital (50 mg/kg). Two hundred inoculation of bacteria. CSF was withdrawn before and at 6, 8, rabbits were used in these studies, 4-8 rabbits for each group.
10, 12, and 20 h after Hib inoculation. Four groups of experiments were performed. First, LOS (20 The final group of experiments involved intracisternal inoculang) and IL-10 at different concentrations (400 pg-100 mg) were tion of Ç10 5 cfu/mL L. monocytogenes and intravenous treatment inoculated intracisternally. At time 0, animals received LOS and with ampicillin (50 mg/kg, two doses 6 h apart), IL-10 (1 mg/kg, IL-10 intracisternally. A second dose of IL-10 was repeated in two doses 1 h apart), and/or dexamethasone (1 mg/kg). Some some experiments 1 h later. CSF was withdrawn before and at 2, animals received no treatment. Treatment was given 14 h after 4, 6, 9, and 24 h after the initial inoculation.
inoculation. CSF samples were withdrawn before and at 14, 16, 20, 24, and 36 h after intracisternal inoculation of L. monocytogenes. Leukocyte concentrations in CSF were determined with a Neubauer hemocytometer (American Optical, Buffalo, NY). Bacterial Table 1 . Cerebrospinal fluid tumor necrosis factor-a (TNF-a) conconcentrations were quantified by plating serial dilutions of CSF centrations in animals receiving different concentrations of IL-10 inonto chocolate agar and sheep blood plates when Hib and L. monotracisternally given concomitantly with lipooligosaccharide.
cytogenes, respectively, were inoculated. The remaining CSF was TNF-a concentration (pg/mL) centrifuged at 2500 g for 10 min, and the supernatant was stored at 070ЊC for further studies.
IL-10
2 h 4 h 6 h TNF-a activity was measured by a cytotoxic assay using L929 cells as previously described [33] . The lower amount of TNF-a range of 100 mg to 5 mg/kg were administered intravenously. ‡ P £ .05 vs. control, 100 mg.
Leukocyte concentrations were not statistically different over this dosage range (data not shown). All dosages of IL-10 decreased CSF TNF-a after inoculation of intracisternal LOS. The greater suppression was observed when a second dose of 10 or dexamethasone therapy (or both) to ceftriaxone significantly reduced bacterial killing at 12 h (figure 1). Significant IL-10 was given 1 h after the initial LOS inoculation (table 2) . Lactate concentrations in CSF were significantly lower in rabreductions in lactate concentrations occurred in animals receiving IL-10 and ceftriaxone compared with concentrations in bits treated with larger amounts of IL-10 (1 and 5 mg/kg). The largest reduction in lactate concentrations occurred when two untreated rabbits (data not shown). Furthermore, the production of TNF-a was significantly reduced when IL-10 was given, doses of IL-10 were given (table 3) .
On the basis of results from the above experiments, a dosage of and this effect was enhanced when IL-10 was combined with dexamethasone (figure 2). 1 mg/kg IL-10 was chosen for experiments using live organisms.
Experiments with intracisternal inoculation of H. influenzae.
Intracisternal inoculation of L. monocytogenes. Therapy was initiated 14 h after intracisternal inoculation. Six treatment Treatment with IL-10 was initiated 6 h after the inoculation of bacteria. IL-10 was given intravenously 15 min before and 1 groups were included: dexamethasone, IL-10, ampicillin alone, ampicillin / dexamethasone, ampicillin / IL-10, and ampicilh after administration of ceftriaxone. Five groups were studied: control animals (no treatment), ceftriaxone alone, ceftriaxone lin / dexamethasone / IL-10. There was also an untreated group. A second dose of IL-10 and ampicillin was given 1 and / dexamethasone, ceftriaxone / IL-10, and ceftriaxone / dexamethasone / IL-10. Cerebrospinal leukocyte concentra-6 h after initial treatment, respectively. No significant differences in leukocyte concentrations for the treatment groups were tions were similar between groups, and the only significant difference occurred at one time point (20 h ) between animals seen (data not shown). Significant differences in CSF bacterial concentrations were observed between ampicillin-treated and treated with ceftriaxone and those treated with ceftriaxone / IL-10 / dexamethasone (data not shown). The addition of ILnontreated rabbits and at 24 h between control and dexametha- . IL-10 is not detected in CSF of healthy controls or patients with viral meningitis [26 -28] . administration of IL-10 or dexamethasone did not adversely affect bacterial concentrations. TNF-a concentrations were sig-IL-10 has immunosuppressive and antiinflammatory properties. This cytokine indirectly prevents antigen-specific T cell proliferanificantly reduced in animals treated with ampicillin / IL-10 and/or dexamethasone (figure 4). Decreases in TNF-a occurred tion. By inhibiting IL-2 from T cells, IL-10 down-regulates the production of proinflammatory cytokines and chemokines by when IL-10 was combined with dexamethasone. Lactate concentrations were significantly lower in animals treated with monocytes and neutrophils [37] . Because these effects are potentially beneficial for treatment of diseases such as meningitis, in ampicillin alone or in combination with IL-10 or dexamethasone (or both) (table 4) .
which high concentrations of proinflammatory cytokines have been significantly correlated with adverse outcome [2, 3] , we evaluated IL-10 in our animal model of meningitis. In these experDiscussion iments, IL-10 significantly reduced TNF-a and lactate concentrations induced by intracisternal inoculation of LOS, Hib, and L. IL-10 has been detected in serum and CSF of patients with sepsis and bacterial meningitis [25 -28, 35, 36] . In septic shock, monocytogenes. This modulation was greater when IL-10 was given in combination with dexamethasone. Previously in this aniserum concentrations of IL-10 correlated with TNF-a concentrations and with severity of disease. Furthermore, IL-10 conmal model of meningitis, we demonstrated that TNF-a was released into CSF immediately after intracisternal injection of endocentrations were significantly higher in patients with shock [25, 35, 36] . Serum IL-10 can be detected in healthy subjects only toxin or Hib, and this was followed by activation and migration of leukocytes into CSF, enhancement of blood-brain barrier perin very low concentrations [36] . In patients with bacterial meningitis, IL-10 was found in CSF [25 -28] , and concentrations meability, and changes in CSF hydrodynamics, cerebral metabolism, and coagulation pathways [1, 10] . correlated well with TNF-a, IL-6, IL-8, and soluble TNF recep- Tumor necrosis factor-a concentrations (pg/mL, mean { SD) in cerebrospinal fluid of rabbits that were intracisternally inoculated with Ç10 5 cfu/mL Listeria monocytogenes and treated intravenously with ampicillin (AMP), dexamethasone (DXM), or IL-10 alone and in combinations. Second dose of IL-10 and AMP was given 1 and 6 h after initial therapy. * P £ .05 vs. others; † P £ .05 vs. AMP alone and non -AMP-treated rabbits (nontreated, DXM-and IL-10 -treated); ‡ P £ .05 vs. non -AMP-treated rabbits (nontreated, DXM-and IL-10 -treated). Table 4 . Cerebrospinal fluid lactate concentrations in rabbits intracisternally inoculated with Ç10 5 cfu/ mL Listeria monocytogenes and treated intravenously with ampicillin (AMP), dexamethasone (DXM), or IL-10 alone or in several combinations or not treated (control group). A second dose of IL-10 and AMP was given 1 and 6 hours after initial therapy. 
